Amalgamated Financial’s AngioDynamics ANGO Stock Holding History

Amalgamated Financial’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$368K	Buy	+17,070	New	+$387K	﹤0.01%	1646

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Amalgamated Financial's ANGO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in AngioDynamics (ANGO) in Q1 2022: 17,070 shares worth $368K. The stake represents ﹤0.01% of the portfolio and ranks #1646 among its holdings.

144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.

Amalgamated Financial held 17,070 shares of AngioDynamics worth $368K as of Q1 2022.
AngioDynamics was a new Amalgamated Financial position in Q1 2022.
AngioDynamics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1646 holding.
144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.